301 related articles for article (PubMed ID: 37453614)
1. Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis.
Guttman-Yassky E; Facheris P; Da Rosa JC; Rothenberg-Lausell C; Del Duca E; David E; Estrada Y; Liu Y; Bose S; Chowdhury M; Munera C; Goncalves J; Nograles K; Kim BS; Lebwohl M
J Allergy Clin Immunol; 2023 Oct; 152(4):916-926. PubMed ID: 37453614
[TBL] [Abstract][Full Text] [Related]
2. Difelikefalin suppresses itch and reduces scratching independent of inflammation in a murine model of atopic dermatitis.
Tamari M; Zamidar L; Ver Heul AM; Nograles K; Goncalves J; Guttman-Yassky E; Lebwohl M; Kim BS
J Allergy Clin Immunol; 2023 Oct; 152(4):927-932. PubMed ID: 37453613
[TBL] [Abstract][Full Text] [Related]
3. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
[TBL] [Abstract][Full Text] [Related]
4. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
5. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
6. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for itch and disease severity in atopic dermatitis.
Lee CH; Yu HS
Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
[TBL] [Abstract][Full Text] [Related]
8. TRPV1 mediates itch-associated scratching and skin barrier dysfunction in DNFB-induced atopic dermatitis mice.
Tang L; Gao J; Cao X; Chen L; Wang H; Ding H
Exp Dermatol; 2022 Mar; 31(3):398-405. PubMed ID: 34608683
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
10. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
[TBL] [Abstract][Full Text] [Related]
11. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
Oh JS; Seong GS; Kim YD; Choung SY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
[TBL] [Abstract][Full Text] [Related]
12. Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis.
Rams A; Baldasaro J; Bunod L; Delbecque L; Strzok S; Meunier J; ElMaraghy H; Sun L; Pierce E
Adv Ther; 2024 Apr; 41(4):1512-1525. PubMed ID: 38363461
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
[TBL] [Abstract][Full Text] [Related]
14. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
Thyssen JP; de Bruin-Weller M; Costanzo A; Grond S; Schuster C; Liu C; Rueda MJ; Chen YF; Pinter A; Bieber T
Adv Ther; 2023 Aug; 40(8):3574-3587. PubMed ID: 37332021
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.
Wong LS; Wu T; Lee CH
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698528
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
17. New mechanism underlying IL-31-induced atopic dermatitis.
Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
[TBL] [Abstract][Full Text] [Related]
18. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
19. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar NK; Smith PK; Yosipovitch G
Clin Rev Allergy Immunol; 2016 Dec; 51(3):263-292. PubMed ID: 25931325
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
